维普期刊资源整合服务平台（V6.5）

69篇 您的检索式：作者名="Borner D"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅱ study of capecitablne and Oxaliplatin in first and second-line treatment of advanced or metastatic colorectal cancer 显示文摘	Borner MM Dietrich D Stupp R	2002	J Clin Oncol2002，20，：	1
2	Adding cetux- imab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a ran- domized phase 11 trial of the swiss group for clinical can- cer research SAKK显示文摘	Borner M Koeberle D Moos RV	2008	Ann Oncol2008，19，7：	1
3	Phase I study of capecitabine and oxaliplatin in first and second-line treatment of advanced or metastatic colorectal cancer显示文摘	Borner MM Dietrich D Stupp R	2002	J Clinl Oncol2002，20，7：	1
4	Phase Ⅱ study of capecitabine and oxaliplatin in first and second-line treatment of advanced or metastatic colorectal cancer显示文摘	Borner MM Dietrich D Stupp R	2002	Clin Oncol2002，20，7：	1
5	Phase Ⅱ study of capecitabine and oxaliplatin in first-and secong-line treatment of advanced or metastatic colorectal cancer显示文摘	Borner MM Dietrich D Stupp R	2002	Clin Oncol2002，20，7：	1
6	A randomised phase Ⅱ trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity 显示文摘	Borner MM Bernhard J Dietrich D	2005	Ann Oneol2005，16，2：	1
7	Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors显示文摘	Bohlen D Borner M Sonntag RW	1999	J Urol1999，161，4：	1
8	Myeloid progenitor cells lacking p53exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation显示文摘	Jabbour A M Daunt C P Green B D Vogel S Gordon L Lee R S Silke N Pearson R B Vandenberg C J Kelly P N Nutt S L Strasser A Borner C Ekert P G	2010	Blood2010，115，2：	1
9	Structural organization of microcystin biosynthesis in Microcystis aeruginosa PCC7806: an integrated peptide-polyketide synthetase system显示文摘	Tillett D Dittmann E Erhard M Dohren H V Borner T Neilan B A	2000	Chem Biol2000，7，：	1
10	Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: A randomized phase 11 trial of the Swiss group for clinical cancer research SAKK 显示文摘	Borner M Koeberle D Von Moos R	2008	Ann Oncol2008，19，7：	1
11	Phase I1 study of capecit- abine and oxaliplatin in first-and second-line treatment of advanced or metastatic colorectal cancer 显示文摘	Borner MM Dietrich D Stupp R	2002	J Clin Oncol2002，20，7：	1
12	Cardiac myxomas: immunohistochemical study of benign and malignant variants显示文摘	Curschellas E Toia D Borner M	1991	Virchows Arch A Pathol Anat Histopathol1991，418，6：	1
13	Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer:a randomized phase Ⅱ trial of the Swiss Group for Clinical Cancer Research SAKK 显示文摘	Borner M Koeberle D von Moos R	2008	Ann Oncol2008，19，7：	1
14	Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine:a multicenter,phase II trial of the Swiss Group for Clinical Cancer Research显示文摘	Koeberle D Saletti P Borner M	2008	J Clin Oncol2008，26，22：	1
15	Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors显示文摘	Borner M Sonntag R W	1999	J Urol,1999，161，4：	1
16	Phase Ⅱ study of capecitabine and oxaliphtin in first- and second- line treatment of advanced or metastatic colorectal cancer显示文摘	Borner MM Dietrich D Stupp R	2002	J CAin Oncol2002，20，7：	1
17	Ading cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer:-a randomized phase II trim of the swiss group for clinical cancer research SAKK 显示文摘	BORNER M KOEBERLE D VON MOOS R	2008	Ann Oncol2008，19，7：	1
18	The impact of cetuximab on the capecitabine plus oxaliplatin (XELOX) combination in first-line treatment of metastatic colorectal cancer (MCC): A randomized phase Ⅱ trial of the Swiss Group for Clinical Cancer Research (SAKK) The impact of cetuximab on the capecitabine plus oxaliplatin (XELOX) combination in first-line treatment of metastatic colorectal cancer (MCC) : A randomized phase Ⅱ trial of the Swiss Group for Clinical Cancer Research (SAKK) 显示文摘	Borner M Mingrone W Koeberle D	2006	Proc Am Soc Clin Oncol2006，，18：	1
19	Friction and bending moments on gear noise exciations 显示文摘	Borner J Houser D R	1996	SAE Transaction1996，，105：	1
20	Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first line treatment of metastatic colorectal cancer: a randomized phase Ⅱ trial of the Swiss Group for Clinical Cancer Research SAKK 显示文摘	Borner M Koeberle D Von Moos R	2008	Ann Oncol2008，19，7：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示